Yonglun Luo Department of Biomedicine, Aarhus University, Denmark
2 protocols

GuangQian Zhou 1 protocol

CuiPing Mo 1 protocol

ChongZhou Fang Lungene Technologies Co., Ltd, China, China,
1 protocol

Yan Zhou
  • Lungene Technologies Co., Ltd, China, China,
  • 1 Author merit

Education

PhD, Aarhus University, Denmark, 2017

Current position

Technical director, Lungene Technologies Co., Ltd, Lungene Technologies Co., Ltd, China

Publications

  1. Kai Xiong*, Yan Zhou*, Kristian Aabo Blichfeld*, Poul Hyttel et al., RNA-Guided Activation of Pluripotency Genes in Human Fibroblasts. Cellular Reprogramming 2017, 19(3):189-198 
  2. Yan Zhou*, Rasha Abdelkadhem Al-Saaidi*, Paula Fernandez Guerra, Kristine K. Freude, Rikke Katrine Jentoft Olsen et al., Mitochondrial Spare Respiratory Capacity Is Negatively Correlated With Nuclear Reprogramming Efficiency. Stem Cells and Development 2017, 26(3):166-176
  3. Kai Xiong*, Yan Zhou*, Poul Hyttel, Lars Bolund, Kristine Karla Freude, and Yonglun Luo, Generation of Induced pluripotent stem cells (iPSCs) stably expressing CRISPR-based synergistic activation mediator (SAM). Stem Cell Research 2016, 17(3):665-669 
  4. Yan Zhou*, Yong Liu*, Dianna Hussmann*, Peter Brøgger*, Rasha Abdelkadhem Al-Saaidi et al., Enhanced genome editing in mammalian cells with a modified dual-fluorescent surrogate system. Cellular and molecular life sciences 2016, 73(13):2543-2563 
  5. Ran Kang*, Yan Zhou*, Shuang Tan, Guangqian Zhou, Lars Aagaard et al., Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity. Stem cell research & therapy 2015, 6:144
1 Protocol published
One-step Derivation of Functional Mesenchymal Stem Cells from Human Pluripotent Stem Cells
Authors:  Yan Zhou, JinQi Liao, ChongZhou Fang, CuiPing Mo, GuangQian Zhou and Yonglun Luo, date: 11/20/2018, view: 411, Q&A: 0
Mesenchymal stem cells (MSCs) are invaluable cell sources for understanding stem cell biology and potential application in tissue engineering and regenerative medicine. The current issues of MSCs that demand to be further addressed are limited ...
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.